Comment on shortened treatment with nimodipine in aneurysmal subarachnoid hemorrhage.
作者信息
Guardiola Begoña, Pérez-Bárcena Jon, Godoy Daniel Agustín, Llompart-Pou Juan Antonio
机构信息
Servei de Medicina Intensiva, Hospital Universitari Son Espases, Palma, Spain.
Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain.
出版信息
Brain Spine. 2025 Aug 19;5:104394. doi: 10.1016/j.bas.2025.104394. eCollection 2025.
Abstract
摘要
相似文献
1
Comment on shortened treatment with nimodipine in aneurysmal subarachnoid hemorrhage.尼莫地平治疗动脉瘤性蛛网膜下腔出血的短程治疗评论
Brain Spine. 2025 Aug 19;5:104394. doi: 10.1016/j.bas.2025.104394. eCollection 2025.
2
Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia.超越尼莫地平：用于治疗动脉瘤性蛛网膜下腔出血血管痉挛和迟发性脑缺血的高级神经保护策略。
Neurosurg Rev. 2024 Jul 5;47(1):305. doi: 10.1007/s10143-024-02543-5.
3
Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Are Old Data Enough to Justify Its Current Treatment Regimen?尼莫地平用于动脉瘤性蛛网膜下腔出血：旧数据是否足以证明其当前治疗方案的合理性？
Neurocrit Care. 2025 Apr;42(2):334-340. doi: 10.1007/s12028-024-02182-0. Epub 2024 Dec 17.
4
Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials.动脉瘤性蛛网膜下腔出血后发病率和死亡率的预防治疗：随机试验的系统评价和网络荟萃分析。
Stroke. 2022 Jun;53(6):1993-2005. doi: 10.1161/STROKEAHA.121.035699. Epub 2022 Mar 31.
5
Comment on the 2023 Guidelines for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage.评论 2023 年颅内动脉瘤性蛛网膜下腔出血患者管理指南。
Stroke. 2023 Oct;54(10):2708-2712. doi: 10.1161/STROKEAHA.123.043541. Epub 2023 Aug 15.
6
Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.静脉注射镁剂与尼莫地平治疗动脉瘤性蛛网膜下腔出血患者的随机研究
Neurosurgery. 2006 Jun;58(6):1054-65; discussion 1054-65. doi: 10.1227/01.NEU.0000215868.40441.D9.
7
Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.动脉瘤性蛛网膜下腔出血后严重难治性脑血管痉挛患者持续动脉内输注尼莫地平：一项可行性研究及结果
Acta Neurochir (Wien). 2015 Dec;157(12):2041-50. doi: 10.1007/s00701-015-2597-z. Epub 2015 Oct 6.
8
Nimodipine after aneurysmal subarachnoid hemorrhage: shortened treatment in an unselected patient cohort.尼莫地平用于动脉瘤性蛛网膜下腔出血：在未选择的患者队列中缩短治疗时间
Brain Spine. 2025 Jul 28;5:104376. doi: 10.1016/j.bas.2025.104376. eCollection 2025.
9
Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.他汀类药物治疗对动脉瘤性蛛网膜下腔出血患者血管痉挛、迟发性脑缺血和功能结局的影响：系统评价和荟萃分析更新。
Stroke. 2010 Jan;41(1):e47-52. doi: 10.1161/STROKEAHA.109.556332. Epub 2009 Oct 29.
10
The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage.尼莫地平经鼻饲管给药对动脉瘤性蛛网膜下腔出血患者结局的影响。
J Pharm Pharm Sci. 2020;23(1):100-108. doi: 10.18433/jpps30960.
本文引用的文献
1
Nimodipine after aneurysmal subarachnoid hemorrhage: shortened treatment in an unselected patient cohort.尼莫地平用于动脉瘤性蛛网膜下腔出血：在未选择的患者队列中缩短治疗时间
Brain Spine. 2025 Jul 28;5:104376. doi: 10.1016/j.bas.2025.104376. eCollection 2025.
2
Does duration of nimodipine therapy impact outcome in aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis.尼莫地平治疗时长对动脉瘤性蛛网膜下腔出血结局有何影响：系统评价与荟萃分析
Neurosurg Rev. 2025 Jun 28;48(1):531. doi: 10.1007/s10143-025-03672-1.
3
Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Are Old Data Enough to Justify Its Current Treatment Regimen?尼莫地平用于动脉瘤性蛛网膜下腔出血：旧数据是否足以证明其当前治疗方案的合理性？
Neurocrit Care. 2025 Apr;42(2):334-340. doi: 10.1007/s12028-024-02182-0. Epub 2024 Dec 17.
4
Transcranial sonography in the critical patient.经颅超声检查在危重症患者中的应用。
Med Intensiva (Engl Ed). 2024 Mar;48(3):165-173. doi: 10.1016/j.medine.2023.07.003.
5
Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.尼莫地平在动脉瘤性蛛网膜下腔出血后迟发性脑缺血高危期剂量减少的风险。
Neurosurg Rev. 2024 Jan 9;47(1):37. doi: 10.1007/s10143-023-02273-0.
6
Twelve controversial questions in aneurysmal subarachnoid hemorrhage.颅内动脉瘤性蛛网膜下腔出血的 12 个争议问题。
Med Intensiva (Engl Ed). 2024 Feb;48(2):92-102. doi: 10.1016/j.medine.2023.09.003. Epub 2023 Nov 10.
7
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.2023 颅内动脉瘤性蛛网膜下腔出血患者管理指南：美国心脏协会/美国卒中协会指南
Stroke. 2023 Jul;54(7):e314-e370. doi: 10.1161/STR.0000000000000436. Epub 2023 May 22.
8
How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage?经颅多普勒超声筛查血管痉挛与动脉瘤性蛛网膜下腔出血后迟发性脑缺血及转归的关系如何？
Acta Neurochir (Wien). 2019 Feb;161(2):385-392. doi: 10.1007/s00701-018-3765-8. Epub 2019 Jan 12.
Zotero 插件